Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Conditions: Chronic Diabetic Foot Ulcers
Interventions: Drug: 5% Bisphosphocin Topical Gel; Drug: Placebo Topical Gel; Drug: 10% Bisphosphocin Topical Gel
Sponsors: Lakewood-Amedex Inc; Professional Education and Research Institute; PrimeVigilance
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 31, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments